Skip to main content
Earnings Labs
Cingulate Inc. logo

Cingulate Inc. (CING)

NASDAQ·Healthcare·Biotechnology

$4.31

+1.17%

Mkt Cap $29.49M

Analyst Ratings

Buy

2

Hold

0

Sell

0

Price Target (3 analysts)

$9.00

Range $9.00 – $9.00

Implied Upside

+108.8%

Consensus $9.00 vs current $4.31